These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8671898)

  • 1. Retention of an albumin-bound furan dicarboxylic acid in patients with chronic renal failure or after a kidney transplant.
    Costigan MG; Yaqoob M; Lindup WE
    Nephrol Dial Transplant; 1996 May; 11(5):803-7. PubMed ID: 8671898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothesis: is accumulation of a furan dicarboxylic acid (3-carboxy-4- methyl-5-propyl-2-furanpropanoic acid) related to the neurological abnormalities in patients with renal failure?
    Costigan MG; Callaghan CA; Lindup WE
    Nephron; 1996; 73(2):169-73. PubMed ID: 8773339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of haemodialysis and continuous ambulatory peritoneal dialysis on the plasma clearance of an albumin-bound furan dicarboxylic acid.
    Costigan MG; Yaqoob M; Lindup WE
    Nephrol Dial Transplant; 1995; 10(5):648-52. PubMed ID: 7566577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, an inhibitor of plasma protein binding in uraemia, with human albumin.
    Henderson SJ; Lindup WE
    Biochem Pharmacol; 1990 Dec; 40(11):2543-8. PubMed ID: 2268372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal organic acid transport: uptake by rat kidney slices of a furan dicarboxylic acid which inhibits plasma protein binding of acidic ligands in uremia.
    Henderson SJ; Lindup WE
    J Pharmacol Exp Ther; 1992 Oct; 263(1):54-60. PubMed ID: 1403803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma clearance in the rat of a furan dicarboxylic acid which accumulates in uremia.
    Costigan MG; Lindup WE
    Kidney Int; 1996 Mar; 49(3):634-8. PubMed ID: 8648903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and physicochemical properties of the furan dicarboxylic acid, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, an inhibitor of plasma protein binding in uraemia.
    Costigan MG; Gilchrist TL; Lindup WE
    J Pharm Pharmacol; 1996 Jun; 48(6):635-40. PubMed ID: 8832500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased bilirubin-binding capacity in uremic serum caused by an accumulation of furan dicarboxylic acid.
    Tsutsumi Y; Maruyama T; Takadate A; Shimada H; Otagiri M
    Nephron; 2000 May; 85(1):60-4. PubMed ID: 10773757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A major endogenous ligand substance involved in renal failure.
    Mabuchi H; Nakahashi H
    Nephron; 1988; 49(4):277-80. PubMed ID: 3412543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient removal of albumin-bound furancarboxylic acid by protein-leaking hemodialysis.
    Niwa T; Asada H; Tsutsui S; Miyazaki T
    Am J Nephrol; 1995; 15(6):463-7. PubMed ID: 8546166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippuric acid and 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid in serum and urine. Analytical approaches and clinical relevance in kidney diseases.
    Liebich HM; Bubeck JI; Pickert A; Wahl G; Scheiter A
    J Chromatogr; 1990 Feb; 500():615-27. PubMed ID: 2329153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of furancarboxylic acids in uremic serum as inhibitors of drug binding.
    Niwa T; Takeda N; Maeda K; Shibata M; Tatematsu A
    Clin Chim Acta; 1988 Apr; 173(2):127-38. PubMed ID: 3378354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous ligands that bind to serum albumin and renal failure.
    Mabuchi H; Nakahashi H
    Nephron; 1990; 55(1):81-2. PubMed ID: 2352581
    [No Abstract]   [Full Text] [Related]  

  • 14. Gas chromatographic and gas chromatographic-mass spectrometric analysis of organic acids in plasma of patients with chronic renal failure.
    Liebich HM; Pickert A; Tetschner B
    J Chromatogr; 1984 Apr; 289():259-66. PubMed ID: 6547446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of renal transplantation on a major endogenous ligand retained in uremic serum.
    Mabuchi H; Nakahashi H; Hamajima T; Aikawa I; Oka T
    Am J Kidney Dis; 1989 Jan; 13(1):49-54. PubMed ID: 2643310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gas chromatographic determination of hippuric acid and a furancarboxylic acid in plasma of patients with kidney diseases.
    Liebich HM; Risler T; Fischer U; Rapp K; Tetschner B; Eggstein M
    J Chromatogr; 1987 Jul; 399():291-4. PubMed ID: 3308938
    [No Abstract]   [Full Text] [Related]  

  • 17. Determination of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, a major endogenous ligand substance in uremic serum, by high-performance liquid chromatography with ultraviolet detection.
    Mabuchi H; Nakahashi H
    J Chromatogr; 1987 Mar; 415(1):110-7. PubMed ID: 3584344
    [No Abstract]   [Full Text] [Related]  

  • 18. Underestimation of serum albumin by the bromcresol purple method and a major endogenous ligand in uremia.
    Mabuchi H; Nakahashi H
    Clin Chim Acta; 1987 Jul; 167(1):89-96. PubMed ID: 3665090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly sensitive simultaneous quantification of indoxyl sulfate and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high-performance liquid chromatography coupled with tandem mass spectrometry.
    Oda A; Suzuki Y; Sato B; Sato H; Tanaka R; Ono H; Ando T; Shin T; Mimata H; Itoh H; Ohno K
    J Sep Sci; 2022 May; 45(10):1672-1682. PubMed ID: 35247297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients?
    Luce M; Bouchara A; Pastural M; Granjon S; Szelag JC; Laville M; Arkouche W; Fouque D; Soulage CO; Koppe L
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29783628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.